Stockreport

IBRX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ImmunityBio, Inc. Investors - Contact Kirby McInerney LLP by May 26, 2026

ImmunityBio, Inc.  (IBRX) 
PDF NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) secur [Read more]